Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd. (ACBM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ACBM · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 5, 2025Next Earnings Date
EPS & Revenue vs. Estimates
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2025 | Aug 5, 2025 | — | -$0.00 | — | — | — | — |
| — Q3 FY2025 | Jul 23, 2025 | — | -$0.00 | — | — | — | — |
| — Q3 FY2025 | Jul 23, 2025 | — | -$0.00 | — | — | — | — |
| — Q2 FY2024 | Jun 17, 2024 | — | -$0.00 | — | — | — | — |
| — Q1 FY2024 | Mar 28, 2024 | — | -$0.00 | — | — | — | — |
| ◌ Q1 FY2024 | Jan 9, 2024 | — | — | — | — | — | — |
| — Q3 FY2023 | Aug 14, 2023 | — | -$0.05 | — | — | — | — |
| — Q3 FY2023 | Jul 21, 2023 | — | -$0.07 | — | $0.00B | — | — |
Earnings Price Reaction
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2025 | Aug 5, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2025 | Jul 23, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2025 | Jul 23, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2024 | Jun 17, 2024 | — | $0.11 | $0.00 | -99.33% |
| — Q1 FY2024 | Mar 28, 2024 | — | $0.11 | $0.00 | -99.33% |
| — Q3 FY2023 | Aug 14, 2023 | — | No price data | $0.75 | — |
| — Q3 FY2023 | Jul 21, 2023 | — | No price data | $0.75 | — |
| — Q3 FY2023 | Jul 21, 2023 | — | No price data | $0.75 | — |
About Earnings & Data Methodology
Acro Biomedical Co., Ltd. (ACBM) most recently reported earnings on August 5, 2025 for Q3 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ACBM earnings date is expected around September 1, 2026.
Each quarter, investors track ACBM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ACBM revenue tab →
Frequently asked questions
ACBM earnings · 4 questionsAcro Biomedical Co., Ltd.'s next earnings report is expected around September 1, 2026. ACBM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ACBM historically reports after market close (AMC).
▸ Source: FMP · Acro Biomedical Co., Ltd. SEC filings · US GAAP · Acro Biomedical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026